Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Grant funding supporting the study ended.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Stanford University | OTHER |
| Charite University, Berlin, Germany | OTHER |
Not provided
Not provided
Not provided
Not provided
Study investigators want to learn more about the underlying biological clock and to see if the timing of that clock can be estimated from a single blood sample.
There is an urgent need for a practical way to assess circadian timing accurately in both general and sleep medicine. The study is designed to assess the levels of different biomarkers in the blood taken from frequent samples across three separate sleep-wake conditions - Conventional/Normal sleep-wake conditions (baseline), extended wake/acute sleep deprivation (constant routine), and during irregular sleep-wake conditions (inverted day). Participants will be asked to complete medical, psychological, and sleep-wake evaluations prior to the study. Upon completion of screening, if eligible, participants will stay 7 consecutive days and nights in the sleep research laboratory within the hospital.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| sleep-wake timing | Behavioral | Study participants will have one inverted day when they are scheduled to sleep ~12h opposite their usual sleep time. | ||
| constant routine | Behavioral | Study participants will spend ~28-50 hours awake, inactive, sitting in bed, in constant lighting and temperature. |
| Measure | Description | Time Frame |
|---|---|---|
| Circadian Phase Timing by BodyTime Assay - Baseline Segment | Circadian phase will be predicted by the BodyTime assay during the baseline segment (study day 3) and will be compared to conventional phase assessment methods. | Baseline Segment (Study day 3) |
| Circadian Phase Timing by BodyTime Assay - Constant Routine | Circadian phase will be predicted by the BodyTime assay during the Constant Routine (study days 4-5) and will be compared to conventional phase assessment methods. | During Constant Routine (Study days 4-5) |
| Circadian Phase Timing by BodyTime Assay - Inverted Day | Circadian phase will be predicted by the BodyTime assay during the Inverted Day (study days 6-7) and will be compared to conventional phase assessment methods. | Inverted Day (Study days 6-7) |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Healthy volunteers will be recruited from the surrounding community.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jeanne F Duffy, MBA, PhD | Brigham and Women's Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Brigham & Women's Hospital | Boston | Massachusetts | 02115 | United States |
Not provided
Not provided
Not provided
Not provided
A genetic blood sample will be collected from each participant. Candidate circadian or sleep genes will be directly sequenced in order to identify polymorphisms or mutations that associate with circadian or sleep phenotypes. Researchers may also conduct genome wide analysis on the DNA sample.
| ID | Term |
|---|---|
| D012893 | Sleep Wake Disorders |
| D020178 | Sleep Disorders, Circadian Rhythm |
| D020919 | Sleep Disorders, Intrinsic |
| D021081 | Chronobiology Disorders |
| ID | Term |
|---|---|
| D009422 | Nervous System Diseases |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D001523 | Mental Disorders |
| D020920 | Dyssomnias |
| D009784 | Occupational Diseases |
Not provided
Not provided